ArticleGeroScience2026
Risk of falls and syncope across frailty levels in hypertensive older adults: a longitudinal study.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In older hypertensive adults, frailty may increase the risk of adverse events associated with blood pressure lowering, including syncope and falls. However, the degree of frailty at which these risks become clinically significant remains uncertain. The study aimed to compare clinical characteristics and the incidence of falls and syncope across different frailty levels among older hypertensive adults. We analyzed data from the longitudinal HYPER-FRAIL study, involving hypertensive outpatients ≥ 75 years undergoing comprehensive geriatric assessment. Frailty was defined according to the Clinical Frailty Scale (CFS). The incidence of a composite outcome of falls and syncope was compared between fit (CFS < 4), mildly frail (CFS = 4-5) and frailer participants (CFS ≥ 6). Among 194 participants (mean age 81 years, 45% male), frailty was absent in 53.6%, mild in 31.4% and moderate-to-severe in 14.9%. A history of falls was more commonly reported among frailer (48.3%) and mildly frail patients (45.9%) compared to fit individuals (21.2%; p < 0.001 for both frailty groups vs fit). Over a median 12-month follow-up, the composite outcome occurred in 13.5% of fit, 31.1% of mildly frail and 31% of frailer participants (p = 0.012 for mild vs absent frailty). Kaplan-Meier curves showed a greater risk in mild frailty (p = 0.003 vs fit participants), with no differences compared to the moderate-to-severe frailty group (p = 0.599). Mild frailty predicted syncope and falls independently of age, prior falls, orthostatic hypotension and depression, but not dementia. Mild frailty (i.e. CFS = 4-5) is common among hypertensive older adults and confers a risk of falls and syncope similar to that of moderate-to-severe frailty.
Indexed as
Identifiers
42133167What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.